AJP - Endo Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (March 20, 2007). doi:10.1152/ajpendo.00629.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/1/E159    most recent
00629.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Subauste, A. R
Right arrow Articles by Burant, C. F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Subauste, A. R
Right arrow Articles by Burant, C. F
Submitted on November 20, 2006
Accepted on March 12, 2007

Role of FoxO1 in FFA induced Oxidative Stress in Adipocytes

Angela R Subauste1 and Charles F Burant2*

1 University of Michgan, Ann Arbor, Michigan, United States
2 Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States

* To whom correspondence should be addressed. E-mail: burantc{at}umich.edu.

Reactive oxygen species (ROS) production has recently been established as an essential contributor in the pathogenesis of obesity associated insulin resistance. The FoxO1 pathway plays a role not only in nutrient sensing but also in regulating ROS production. Here we exposed adipocytes to free fatty acids and demonstrated that FoxO1 protein levels decrease in a dose dependent manner. The FoxO1 downregulation correlated with an increase in the production of ROS and a proinflammatory adipokine pattern characterized by a decrease in adiponectin and an increase in IL-6, PAI-1 and MCP-1 mRNA expression levels. Similarly, a decrease in FoxO1 protein levels was seen in adipocytes of db/db mice when compared to controls. Treatment with the sirtuin agonist resveratrol which translocates FoxO1 to the nucleus increased FoxO1 protein levels in adipocytes exposed to FFA. This correlated with a decrease in the generation of ROS and a partial reversal of the proinflammatory adipokine pattern. Together these results indicate that the insulin resistant adipocyte produced by the exposure to a high concentration of fatty acids is characterized by decreased levels of FoxO1. These data also suggests that the modulation of the Sirt1/FoxO1 pathway is a potentially useful therapeutic target for the obesity induced dysfunctional adipocyte.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Takahashi, S. Yamaguchi, T. Shimoyama, H. Seki, K. Miyokawa, H. Katsuta, T. Tanaka, K. Yoshimoto, H. Ohno, S. Nagamatsu, et al.
JNK- and I{kappa}B-dependent pathways regulate MCP-1 but not adiponectin release from artificially hypertrophied 3T3-L1 adipocytes preloaded with palmitate in vitro
Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E898 - E909.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.